Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Pacemakers and defibrillators for the survival of patients suffering from heart insufficiency

07.06.2005


Studies recently carried out at the University Hospital of the University of Navarra show that cardiac resynchronisation therapy using pacemakers and defibrillators improves the survival and quality of life of patients suffering from heart insufficiency and disorders of the blood-flow system.




Cardiac resynchronisation

One of the advances for heart insufficiency developed over the past few years has been the incorporation of biventricular pacemakers and defibrillators. Known as cardiac resynchronisation therapy, their implantation provides the advantage of increasing the performance of the heart in a number of patients with this pathology. In some cases, the heart insufficiency not only involves a loss of contractile force, but also an alteration in the synchronisation of the heart. That is to say, contraction occurs with little force and, moreover, in a disordered manner and, thus, the heart’s performance or yield is notably worsened.



With cardiac resynchronisation the desynchronisation of the heart contractions caused by electrical pulse disorders are minimised, and so the heart recovers part of its normal function. This results in a decrease in the symptoms, especially fatigue, and in a greater survival rate for patients.

Cardiac resynchronisation therapy can be carried out in an isolated manner (with a specific pacemaker) or with a defibrillator, which also has the ability to treat the cardiac arrhythmias that can occur with some of these patients. In some cases the implantation is began in a conventional manner through the right auricle and ventricle, the left ventricle being subsequently accessed through the coronary venous system, and up to three electrodes implanted. The procedure is carried out under local anaesthetic, lasts between one and two hours and the postoperative stage is rapid, thus enabling the patient to be released in one or two days.

Irati Kortabitarte | alfa
Further information:
http://www.basqueresearch.com

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>